Cargando…
Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea
INTRODUCTION: Rosacea is a chronic, inflammatory dermatosis which develops due to the effect of genetic and environmental factors. AIM: To evaluate the oxidative stress in rosacea patients by measuring serum total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI) and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041719/ https://www.ncbi.nlm.nih.gov/pubmed/30008650 http://dx.doi.org/10.5114/ada.2018.76228 |
_version_ | 1783339034437746688 |
---|---|
author | Erdogan, Hilal Kaya Bulur, Isil Kocaturk, Evin Saracoglu, Zeynep Nurhan Alatas, Ozkan Bilgin, Muzaffer |
author_facet | Erdogan, Hilal Kaya Bulur, Isil Kocaturk, Evin Saracoglu, Zeynep Nurhan Alatas, Ozkan Bilgin, Muzaffer |
author_sort | Erdogan, Hilal Kaya |
collection | PubMed |
description | INTRODUCTION: Rosacea is a chronic, inflammatory dermatosis which develops due to the effect of genetic and environmental factors. AIM: To evaluate the oxidative stress in rosacea patients by measuring serum total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI) and advanced oxidation protein products (AOPP) levels in our study. MATERIAL AND METHODS: Our study included rosacea patients and healthy volunteers aged between 18 and 65 years. Total antioxidant status, TOS and AOPP levels were measured and OSI was calculated. RESULTS: The study included 70 rosacea patients and 30 healthy volunteers as a control group. When TAS, TOS, OSI and AOPP levels were compared between rosacea and control groups, there was no difference for OSI levels; while TAS, TOS and AOPP levels were significantly higher in the rosacea group (p = 0.151, p = 0.013, p = 0.034, p = 0.017, respectively). In the rosacea group, there was no correlation between TAS, TOS, OSI and AOPP levels and disease duration. Besides there was no difference between family history, rosacea type, symptom frequency and ocular involvement and TAS, TOS, OSI and AOPP levels in the rosacea group. CONCLUSIONS: We observed that serum TAS, TOS and AOPP levels were significantly higher in rosacea patients, but there was no significant difference among the disease activity parameters. These results can support the role of oxidative stress in the pathogenesis of rosacea. |
format | Online Article Text |
id | pubmed-6041719 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Termedia Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-60417192018-07-13 Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea Erdogan, Hilal Kaya Bulur, Isil Kocaturk, Evin Saracoglu, Zeynep Nurhan Alatas, Ozkan Bilgin, Muzaffer Postepy Dermatol Alergol Original Paper INTRODUCTION: Rosacea is a chronic, inflammatory dermatosis which develops due to the effect of genetic and environmental factors. AIM: To evaluate the oxidative stress in rosacea patients by measuring serum total antioxidant status (TAS), total oxidant status (TOS), oxidative stress index (OSI) and advanced oxidation protein products (AOPP) levels in our study. MATERIAL AND METHODS: Our study included rosacea patients and healthy volunteers aged between 18 and 65 years. Total antioxidant status, TOS and AOPP levels were measured and OSI was calculated. RESULTS: The study included 70 rosacea patients and 30 healthy volunteers as a control group. When TAS, TOS, OSI and AOPP levels were compared between rosacea and control groups, there was no difference for OSI levels; while TAS, TOS and AOPP levels were significantly higher in the rosacea group (p = 0.151, p = 0.013, p = 0.034, p = 0.017, respectively). In the rosacea group, there was no correlation between TAS, TOS, OSI and AOPP levels and disease duration. Besides there was no difference between family history, rosacea type, symptom frequency and ocular involvement and TAS, TOS, OSI and AOPP levels in the rosacea group. CONCLUSIONS: We observed that serum TAS, TOS and AOPP levels were significantly higher in rosacea patients, but there was no significant difference among the disease activity parameters. These results can support the role of oxidative stress in the pathogenesis of rosacea. Termedia Publishing House 2018-06-18 2018-06 /pmc/articles/PMC6041719/ /pubmed/30008650 http://dx.doi.org/10.5114/ada.2018.76228 Text en Copyright: © 2018 Termedia Sp. z o. o. http://creativecommons.org/licenses/by-nc-sa/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license. |
spellingShingle | Original Paper Erdogan, Hilal Kaya Bulur, Isil Kocaturk, Evin Saracoglu, Zeynep Nurhan Alatas, Ozkan Bilgin, Muzaffer Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea |
title | Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea |
title_full | Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea |
title_fullStr | Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea |
title_full_unstemmed | Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea |
title_short | Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea |
title_sort | advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6041719/ https://www.ncbi.nlm.nih.gov/pubmed/30008650 http://dx.doi.org/10.5114/ada.2018.76228 |
work_keys_str_mv | AT erdoganhilalkaya advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea AT bulurisil advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea AT kocaturkevin advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea AT saracogluzeynepnurhan advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea AT alatasozkan advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea AT bilginmuzaffer advancedoxidationproteinproductsandserumtotaloxidantantioxidantstatuslevelsinrosacea |